Showing results (191-200 of 203) with videos related to
Sort By:
Pageof 21
Journal of Gastroenterology and Hepatology|August 26, 2018
Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter studyMasanori Atsukawa, Akihito Tsubota, Hidenori Toyoda, et al.Developmental Cell|March 23, 2021
Filopodium-derived vesicles produced by MIM enhance the migration of recipient cellsTamako Nishimura, Takuya Oyama, Hooi Ting Hu, et al.Journal of Occupational Health|June 30, 2025
Physical activity interventions delivered through digital health technology for improving workers' mental health symptoms: a systematic review and meta-analysisSatoru Kanamori, Kotaro Imamura, Yuta Inagawa, et al.The EMBO Journal|June 15, 2022
Nucleome programming is required for the foundation of totipotency in mammalian germline developmentMasahiro Nagano, Bo Hu, Shihori Yokobayashi, et al.Journal of Gastroenterology|June 1, 2017
Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in JapanGoki Suda, Norihiro Furusyo, Hidenori Toyoda, et al.Hinyokika Kiyo. Acta Urologica Japonica|July 19, 2008
[Multi-institute survey on actual conditions of urologic management for severe bladder dysfunction after hysterectomy]Koji Yoshimura, Toshiyuki Kamoto, Takuya Okada, et al.Arerugi = [Allergy]|November 15, 2023
[A MULTICENTER CLINICAL SURVEY ABOUT THE PREVALENCE OF JAPANESE CYPRESS POLLINOSIS AND THE EFFICACY OF SUBLINGUAL IMMUNOTHERAPY WITH JAPANESE CEDAR POLLEN EXTRACT DURING JAPANESE CYPRESS POLLEN DISPERSAL PERIOD]Aiko Oka, Atsushi Yuta, Yukiko Okawa, et al.Journal of Gastroenterology and Hepatology|October 15, 2019
Real-world experience of 12-week direct-acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infectionHidenori Toyoda, Masanori Atsukawa, Tsunamasa Watanabe, et al.Journal of Viral Hepatitis|July 7, 2019
Evaluation of 8-week glecaprevir/pibrentasvir treatment in direct-acting antiviral-naïve noncirrhotic HCV genotype 1 and 2infected patients in a real-world setting in JapanHiroki Ikeda, Tsunamasa Watanabe, Masanori Atsukawa, et al.The Journal of Allergy and Clinical Immunology. Global|April 28, 2025
Real-world efficacy of sublingual immunotherapy with Japanese cedar pollen for cypress pollinosisAiko Oka, Tamami Yamashita, Kengo Kanai, et al.Pageof 21